www.nccn.org Open in urlscan Pro
67.216.68.28  Public Scan

Form analysis
0 forms found in the DOM

Text Content

View Upcoming and Recorded Patient Webinars

Navbar
 * About
 * Donate
 * News
 * Store

When autocomplete results are available use up and down arrows to review and
enter to select.
 * Login

My Pages

Subscriptions

Order History

Account Settings Edit Account


Log Out
Navbar
 * Guidelines
 * Compendia & Templates
 * Education & Research
 * Patient Resources
 * Business & Policy
 * Global

Guidelines COVID-19 Resources Treatment by Cancer Type Detection, Prevention,
and Risk Reduction Supportive Care Specific Populations Guidelines for Patients
Guidelines With Evidence Blocks Framework for Resource Stratification Harmonized
Guidelines International Adaptations and Translations Guidelines Process
Guidelines Panels and Disclosure Submissions, Licensing, and Permissions
Recently Updated Guidelines
Acute Lymphoblastic Leukemia Acute Myeloid Leukemia Anal Carcinoma Basal Cell
Skin Cancer B-Cell Lymphomas Bladder Cancer Bone Cancer Breast Cancer Central
Nervous System Cancers Cervical Cancer Chronic Lymphocytic Leukemia/Small
Lymphocytic Lymphoma Chronic Myeloid Leukemia Colon Cancer Dermatofibrosarcoma
Protuberans Esophageal and Esophagogastric Junction Cancers Gastric Cancer
Gastrointestinal Stromal Tumors (GIST) Gestational Trophoblastic Neoplasia Hairy
Cell Leukemia Head and Neck Cancers
Hepatobiliary Cancers Histiocytic Neoplasms Hodgkin Lymphoma Kaposi Sarcoma
Kidney Cancer Malignant Peritoneal Mesothelioma Malignant Pleural Mesothelioma
Melanoma: Cutaneous Melanoma: Uveal Merkel Cell Carcinoma Multiple Myeloma
Myelodysplastic Syndromes Myeloid/Lymphoid Neoplasms with Eosinophilia and
Tyrosine Kinase Fusion Genes Myeloproliferative Neoplasms Neuroendocrine and
Adrenal Tumors Non-Small Cell Lung Cancer Occult Primary Ovarian
Cancer/Fallopian Tube Cancer/Primary Peritoneal Cancer Pancreatic Adenocarcinoma
Pediatric Acute Lymphoblastic Leukemia
Pediatric Aggressive Mature B-Cell Lymphomas Pediatric Hodgkin Lymphoma Penile
Cancer Primary Cutaneous Lymphomas Prostate Cancer Rectal Cancer Small Bowel
Adenocarcinoma Small Cell Lung Cancer Soft Tissue Sarcoma Squamous Cell Skin
Cancer Systemic Light Chain Amyloidosis Systemic Mastocytosis T-Cell Lymphomas
Testicular Cancer Thymomas and Thymic Carcinomas Thyroid Carcinoma Uterine
Neoplasms Vulvar Cancer Waldenström Macroglobulinemia / Lymphoplasmacytic
Lymphoma Wilms Tumor (Nephroblastoma)
Breast Cancer Risk Reduction Breast Cancer Screening and Diagnosis Colorectal
Cancer Screening
Genetic/Familial High-Risk Assessment: Breast, Ovarian, and Pancreatic
Genetic/Familial High-Risk Assessment: Colorectal Lung Cancer Screening
Prostate Cancer Early Detection
Adult Cancer Pain Antiemesis Cancer-Associated Venous Thromboembolic Disease
Cancer-Related Fatigue
Distress Management Hematopoietic Cell Transplantation Hematopoietic Growth
Factors Management of Immunotherapy-Related Toxicities
Palliative Care Prevention and Treatment of Cancer-Related Infections Smoking
Cessation Survivorship
Adolescent and Young Adult (AYA) Oncology
Cancer in People with HIV
Older Adult Oncology
Acute Lymphoblastic Leukemia (adult) Acute Lymphoblastic Leukemia (pediatric)
Acute Myeloid Leukemia Adolescents and Young Adults with Cancer Anal Cancer
Anemia and Neutropenia - Low Red and White Blood Cell Counts Basal Cell Skin
Cancer B-Cell Lymphomas - Diffuse Large B-Cell Lymphoma B-Cell Lymphomas -
Follicular Lymphoma B-Cell Lymphomas - Mantle Cell Lymphoma Bladder Cancer Bone
Cancer Brain Cancer - Gliomas Breast Cancer - DCIS Breast Cancer Breast Cancer -
Invasive Breast Cancer Breast Cancer - Metastatic Breast Cancer Central Nervous
System Cancers - Primary Central Nervous System Lymphoma Cervical Cancer Chronic
Lymphocytic Leukemia Chronic Myeloid Leukemia
Colon Cancer Colorectal Cancer Screening Distress Management - Distress During
Cancer Care Esophageal Cancer Gallbladder and Bile Duct Cancers Head and Neck
Cancers - Nasopharyngeal Cancer Head and Neck Cancers - Oral Cancers Head and
Neck Cancers - Oropharyngeal Cancer Hodgkin Lymphoma Immunotherapy Side Effects:
CAR T-Cell Therapy Immunotherapy Side Effects: Immune Checkpoint Inhibitors
Kidney Cancer Liver Cancer Lung Cancer Screening Malignant Pleural Mesothelioma
Melanoma Multiple Myeloma Mycosis Fungoides/Sézary Syndrome Myelodysplastic
Syndromes Myeloproliferative Neoplasms
Nausea and Vomiting Neuroendocrine Tumors Non-Small Cell Lung Cancer - Early and
Locally Advanced Non-Small Cell Lung Cancer - Metastatic Ovarian Cancer
Pancreatic Cancer Peripheral T-Cell Lymphoma Primary Cutaneous Lymphomas
Prostate Cancer: Advanced Stage Prostate Cancer: Early Stage Rectal Cancer Small
Cell Lung Cancer Soft Tissue Sarcoma Squamous Cell Skin Cancer Stomach Cancer
Survivorship Care for Cancer-Related Late and Long-Term Effects Survivorship
Care for Healthy Living Thyroid Cancer Uterine Cancer Waldenström
Macroglobulinemia
About Clinical Practice Guidelines Development and Update of Guidelines
Transparency Process Guidelines Panels Meeting Schedule

Disclosure Policies and Potential Conflicts of Interest
Guidelines Panels
Guideline Steering Committee
Licensing and Permissions Permissions Linking Permissions Distress Tool
Permissions Request Form Submission Request to the Guidelines Panels Submission
Request History
Academic Publication Information
Compendia & Templates Compendia Chemotherapy Order Templates
NCCN Compendia Drugs and Biologics Compendium Biomarkers Compendium
Imaging AUC Compendium Radiation Therapy Compendium Subscribe to NCCN Compendium
Recognition Program
Browse by Cancer Type View Chemotherapy Order Templates User Guide
EHR Integration Chemotherapy Order Templates Committee
Subscribe to NCCN Templates Chemotherapy Order Templates Reviewer
Acknowledgement
Education & Research Events and Programs Oncology Research Program JNCCN
Publications
Continuing Education Calendar of Events
Annual Conference 2022 Annual Conference Sponsor and Exhibitor Prospectus
Annual Congress: Hematologic Malignancies
Oncology Research Program (ORP) Current Opportunities ORP Recent News ORP Grant
History
Scientific Publications Clinical Trials Young Investigator Awards Informed
Consent Language Database
Best Practices for Biorepositories Shared Resources Disclosure Policy
About JNCCN
Subscribe to JNCCN
JNCCN Email Updates
Business & Policy Business Policy and Advocacy Program
Corporate Council Academy Trends U.S. Surveys Trends Global Surveys Flash
Updates
Order Free Pocket Guidelines and Guidelines for Patients Advertising
Opportunities Research Tools: REMS Employer Toolkit Employer Resources
Virtual Reimbursement Resource Room and App Health Information Technology
Licenses Embargo Policy Firewall Policy
Policy and Advocacy Program Oncology Policy Summits
Policy Priority: Improve and Facilitate Quality Cancer Care Policy Priority:
Ensure Patient Accessibility
Policy Priority: Increase Use of Guidelines State Oncology Society Forum
Global Global Clinical Resources Global Support Opportunities Contact NCCN
Global Global Events
NCCN Framework For Resource Stratification Harmonized Guidelines
International Adaptations and Translations Regions

Global Corporate Council Global Academy
Trends Global Surveys eBulletin Global Edition

 1. Home
 2. Guidelines
 3. NCCN Mobile App


NCCN MOBILE APPS

 * COVID-19 Resources
 * Treatment by Cancer Type
 * Detection, Prevention, and Risk Reduction
 * Supportive Care
 * Specific Populations
 * Guidelines for Patients
 * Guidelines With Evidence Blocks
 * Framework for Resource Stratification
 * Harmonized Guidelines
 * International Adaptations and Translations
 * Guidelines Process
   * About Clinical Practice Guidelines
   * Development and Update of Guidelines
   * Transparency Process
   * Guidelines Panels Meeting Schedule
 * Guidelines Panels and Disclosure
   * Disclosure Policies and Potential Conflicts of Interest
   * Guidelines Panels
   * Guideline Steering Committee
 * Submissions, Licensing, and Permissions
   * Licensing and Permissions
   * Permissions Linking
   * Permissions Distress Tool
   * Permissions Request Form
   * Submission Request to the Guidelines Panels
   * Submission Request History
   * Academic Publication Information
 * Recently Updated Guidelines

Millions of people access the NCCN Guidelines® and associated resources via
handheld devices. NCCN provides three apps to facilitate easy access to the most
up-to-date clinical content for oncology stakeholders. Apps are available for
those interested in NCCN Guidelines, global resources, NCCN Guidelines for
Patients®, and reimbursement resources.


VIRTUAL LIBRARY OF NCCN GUIDELINES® APP

Available for Phone/iPad and Android Smartphone/Tablet. This easy-to-use and
convenient format further assists health care professionals in their
implementation of the NCCN Guidelines®, thus improving the quality and
effectiveness of care provided to patients with cancer.

Key Features:

 * Easy access to NCCN Guidelines®
 * Hyperlinks within the Guidelines
 * Ability to quickly share Guidelines
 * Optimized search and viewing options

Did you know that in addition to NCCN Guidelines you can also access the
following resources via the app?

 * NCCN Guidelines for Patients®
 * NCCN Framework™
 * NCCN Harmonized Guidelines™
 * International Adaptations and Translations of NCCN Guideline
 * NCCN Guidelines with NCCN Evidence Blocks™

For Information on supporting the NCCN Guidelines Mobile Application, or
distribution opportunities, please visit the Supporter Opportunities page.


NCCN PATIENT GUIDES FOR CANCER APP

Available for iPhone/iPad and Android Smartphone/Tablet. 

People with cancer and caregivers can access the patient-friendly NCCN
Guidelines for Patients® via the app for expert information they can use to talk
to their health care team about the best treatment options.

 * Step-by-step guides to cancer treatment options
 * Questions to ask doctors
 * Patient-friendly illustrations
 * Based on information doctors use
 * Ability to print, download, and share patient guidelines
 * Includes language translations

For information on supporting the NCCN Patient Guides for Cancer Mobile
Application, or distribution opportunities, please contact the NCCN Foundation.


NCCN REIMBURSEMENT RESOURCE APP

Available for iPhone/iPad and Android Smartphone/Tablet.

The cost of cancer care continues to rise and patients with cancer and their
caregivers often struggle to pay for therapy. As a response to these ongoing
challenges, help is available through the NCCN Reimbursement Resource App; users
are able to search for available resources and payment assistance programs.

 * Step-by-step guides to cancer treatment options
 * Questions to ask doctors
 * Patient-friendly illustrations
 * Based on information doctors use
 * Ability to print, download, and share patient guidelines
 * Includes language translations

For information on participating in the NCCN Reimbursement Resource App or other
support opportunities, please contact Jennifer Tredwell.

 

To use the NCCN Guidelines App, an individual must be a registered user on
NCCN.org. There is no fee to become a registered user on NCCN.org and to view
the NCCN Guidelines. Become a registered user (free) on NCCN.org.

A new registration can be created from the welcome screen of the iPad and Google
Play Apps as well.

Apple and the Apple logo are trademarks of Apple Inc., registered in the U.S.
and other countries. App Store is a service mark of Apple Inc., registered in
the U.S. and other countries. Google Play and the Google Play logo are
trademarks of Google Inc. Android is a trademark of Google Inc.

Navbar
 * End User License Agreement
 * Privacy Policy
 * Legal Notices
 * Accessibility
 * Support NCCN
 * Developer API
 * Contact

3025 Chemical Road, Suite 100, Plymouth Meeting, PA 19462
Phone: 215-690-0300
Fax: 215-690-0280
 * 
 * 
 * 
 * 
 * 

Copyright © 2021 National Comprehensive Cancer Network, All Rights Reserved.

No portion of this Site or any NCCN Content may be copied, transferred,
reproduced, modified, or otherwise used for any purpose without NCCN’s express
written permission.
See Legal Notices Section for additional notices and terms governing your use of
this Site.